Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in New Executive Leadership Role

NEW YORK, August 8, 2022 /PRNewswire/ — Pierre Hoehn joins Cohen Veterans Bioscience (CVB) as Executive Vice President, Strategic Marketing, Development and Impact. In this newly created role, Hoehn will lead the external affairs, communications and development functions for New YorkCVB non-profit dedicated to improving brain health. Hoehn will report to CVB Founder, CEO and President, Dr. Magali HaasMD, PhD.

Pierre Hoehn is a recognized leader in the healthcare industry with over 25 years of experience in various business and strategic roles, primarily at Johnson & Johnson. Hoehn was most recently head of business strategy for J&J Science for Minds, a new organization focused on innovative development models and digital solutions to combat serious mental illness and dementia. In this role, he developed the strategy, portfolio recommendations, investment approach, external collaborations and business models for new digital mental health and brain health business ventures.

“We are delighted to have Peter join CVB in this important new leadership role. I had the privilege of partnering with Peter to advance brain therapy during our joint tenure at Johnson & Johnson and more recently in his capacity. as a member of the steering committee of the CVB-led Brain Health Nexus initiative. I am confident that he will add impactful health business expertise to our organization at a time of intense growth and development,” said Dr. Haas .

Throughout his career, Peter has demonstrated the ability to develop insight-driven strategies in complex markets and to mobilize internal and external partners to achieve results. He brings extensive commercial, strategic and leadership experience in pharma, diagnostics, digital health and precision medicine, including brand positioning and messaging, reimbursement and market access, global launches, organizational capacity building, business model innovation, new opportunity assessment, business development and policy.

Peter began his career as a corporate lawyer and entered the pharmaceutical industry as a solicitor for Bristol Myers Squibb. After a short period as a lawyer, Peter held various strategy, marketing and sales management positions at BMS before joining Johnson & Johnson in 2003.

Peter holds a BA in Government and Economics from the William and Mary Collegeand a JD of New York University.

About Cohen Veterans Bioscience
Cohen Veterans Bioscience (CVB) is a 501(c)(3) nonprofit biomedical research and technology organization dedicated to improving the brain health of millions of veterans and civilians by accelerating precision diagnostics and tailored therapies. CVB harnesses the power of biotechnology and advanced analytics and promotes best practices in finding evidence-based, replicable and effective solutions. To support and learn more about our research efforts, visit www.cohenveteransbioscience.org.

SOURCE Cohen Veterans Biosciences